Reporting Manager
Trails Edge Capital Partners, LP
Symbol
PMN
Shares outstanding
9,429,061 shares
Disclosed Ownership
933,477 shares
Ownership
9.9%
Form type
SCHEDULE 13G
Filing time
10 Feb 2026, 16:15:21 UTC
Date of event
03 Feb 2026

Quoteable Key Fact

"Trails Edge Capital Partners, LP disclosed 9.9% ownership in ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN) on 03 Feb 2026."

Quick Takeaways

  • Trails Edge Capital Partners, LP filed SCHEDULE 13G for ProMIS Neurosciences Inc. Common Shares, no par value per share (PMN).
  • Disclosed ownership: 9.9%.
  • Date of event: 03 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Feb 2026, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 9.9% 933,477 933,477 0 /s/ Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 9.9% 933,477 933,477 0 /s/ Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 9.9% 933,477 933,477 0 /s/ Ortav Yehudai Ortav Yehudai / Individual
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .